Associated Papers
The role of the genomic mutation signature and tumor mutation burden on relapse risk prediction in head and neck squamous cell carcinoma after concurrent chemoradiotherapy.
Wang HC et al.
Experimental & Molecular Medicine, 2023
37121970 (PubMed )
Supplement: 12276_2023_984_MOESM1_ESM.pdf
Select a paper to view details